Correlation between photoreceptor layer integrity and visual function in patients with stargardt disease: Implications for gene therapy

Investigative Ophthalmology and Visual Science

Volumn 53, Issue 8, 2012, Pages 4409-4415

  Testa, Francesco ^a   Rossi, Settimio ^a   Sodi, Andrea ^b   Passerini, Ilaria ^c   Di orio, Valentina ^a   Della Corte, Michele ^a   Banfi, Sandro ^a,d   Surace, Enrico Maria ^d   Menchini, Ugo ^b   Auricchio, Alberto ^d,e   Simonelli, Francesca ^a,d  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

^b UNIVERSITY OF FLORENCE   (Italy)

^c CAREGGI UNIVERSITY HOSPITAL   (Italy)

^d TELETHON INSTITUTE OF GENETICS AND MEDICINE TIGEM   (Italy)

^e UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

GLUTAMIC ACID; GLYCINE;

ABCA 4 GENE; ADOLESCENT; ADULT; AGE; AGED; ALLELE; ARTICLE; AUTOFLUORESCENCE; CHILD; DISEASE CLASSIFCATION; DNA SEQUENCE; ELECTRORETINOGRAPHY; EYE FUNDUS; GENE; HUMAN; MAJOR CLINICAL STUDY; MUTATIONAL ANALYSIS; PERIMETRY; PHOTORECEPTOR; PHOTORECEPTOR INNER SEGMENT; PHOTORECEPTOR OUTER SEGMENT; PRIORITY JOURNAL; RETINA FOVEA; RETINA MACULA LUTEA; SCHOOL CHILD; SPECTRAL DOMAIN OPTICAL COHERENCE TOMOGRAPHY; STARGARDT DISEASE; VISION; VISUAL ACUITY;

ADOLESCENT; ADULT; AGED; ATP-BINDING CASSETTE TRANSPORTERS; CHILD; CORNEAL DYSTROPHIES, HEREDITARY; DNA MUTATIONAL ANALYSIS; ELECTRORETINOGRAPHY; FLUORESCEIN ANGIOGRAPHY; GENE THERAPY; HUMANS; MIDDLE AGED; RETINA; RETINAL PHOTORECEPTOR CELL INNER SEGMENT; RETINAL PHOTORECEPTOR CELL OUTER SEGMENT; TOMOGRAPHY, OPTICAL COHERENCE; VISUAL ACUITY; VISUAL FIELD TESTS; VISUAL FIELDS; YOUNG ADULT;

EID: 84863738695     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.11-8201     Document Type: Article

References (29)

1. Stargardt K. ̈Uber familïare progressive degenerationen im kindesalter. Graefes Arch Clin Exp Ophthalmol. 1909;71:534-550.
2. Cideciyan AV, Aleman TS, Swider M, et al. Mutations in ABCA4 result in accumulation of lipofuscin before slowing of the retinoid cycle: a reappraisal of the human disease sequence. Hum Mol Genet. 2004;13:525-534.
3. Rotenstreich Y, Fishman GA, Anderson RJ. Visual acuity loss and clinical observations in a large series of patients with Stargardt's disease. Ophthalmology. 2003;110:1151-1158.
4. Armstrong JD, Meyer D, Xu S, et al. Long-term follow-up of Stargardt's disease and fundus flavimaculatus. Ophthalmology. 1998;105:448-458.
5. Fishman GA, Farber M, Patel BS, et al. Visual acuity loss in patients with Stargardt's macular dystrophy. Ophthalmology. 1987;94:809-814.
6. Allikmets R, Singh N, Sun H, et al. A photoreceptor cellspecific ATP-binding transporter gene (ABCR) is mutated in recessive Stargardt macular dystrophy. Nat Genet. 1997;15: 236-246.
7. Sun H, Nathans J. Mechanistic studies of ABCR: the ABC transporter in photoreceptor outer segments responsible for autosomal recessive Stargardt disease. J Bioenerg Biomembr. 2001;33:523-530.
8. Kiernan DF, Mieler WF, Hariprasad SM. Spectral-domain optical coherence tomography: a comparison of modern highresolution retinal imaging systems. Am J Ophthalmol. 2010; 149:18-31.
9. Fishman GA, Stone EM, Grover S, Derlacki DJ, Haines HL, Hockey RR. Variation of clinical expression in patients with Stargardt dystrophy and sequence variations in the ABCR gene. Arch Ophthalmol. 1999;117:504-510.
10. Marmor MF, Holder GE, Seeliger MW, Yamamoto S. Standard for clinical electroretinography (2004 update). Doc Ophthalmol. 2004;108:107-114.
11. Lois N, Holder GE, Bunce C, Fitzke FW, Bird AC. Phenotypic subtypes of Stargardt macular dystrophy-fundus flavimaculatus. Arch Ophthalmol. 2001;119:359-369.
12. Hood DC, Bach M, Brigell M, et al. ISCEV guidelines for clinical multifocal electroretinography (2007 edition). Doc Ophthalmol. 2008;116:1-11.
13. Kretschmann U, Seeliger MW, Ruether K, Usui T, Apfelstedt-Sylla E, Zrenner E. Multifocal electroretinography in patients with Stargardt's macular dystrophy. Br J Ophthalmol. 1998;82: 267-275.
14. Ko TH, Fujimoto JG, Schuman JS, et al. Comparison of ultrahigh and standard-resolution optical coherence tomography for imaging macular pathology. Ophthalmology. 2005; 112:1922. e1-15. Available at: http://www.ophsource.org/ periodicals/ophtha. Accessed June 29, 2011.
15. Midena E, Vujosevic S, Convento E, Manfre' A, Cavarzeran F, Pilotto E. Microperimetry and fundus autofluorescence in patients with early age-related macular degeneration. Br J Ophthalmol. 2007;91:1499-1503.
16. Simonelli F, Testa F, Zernant J, et al. Genotype-phenotype correlation in Italian families with Stargardt disease. Ophthalmic Res. 2005;37:159-167.
17. Sodi A, Bini A, Passerini I, Forconi S, Menchini U, Torricelli F. Different patterns of fundus autofluorescence related to ABCA4 gene mutations in Stargardt disease. Ophthalmic Surg Lasers Imaging. 2010;41:48-53.
18. Delori FC, Staurenghi G, Arend O, Dorey CK, Goger DG, Weiter JJ. In vivo measurement of lipofuscin in Stargardt's disease-Fundus flavimaculatus. Invest Ophthalmol Vis Sci. 1995;36:2327-2331.
19. Fishkin NE, Sparrow JR, Allikmets R, Nakanishi K. Isolation and characterization of a retinal pigment epithelial cell fluorophore: an all-trans-retinal dimer conjugate. Proc Natl Acad Sci U S A. 2005;102:7091-7096.
20. Karan G, Lillo C, Yang Z, et al. Lipofuscin accumulation, abnormal electrophysiology, and photoreceptor degeneration in mutant ELOVL4 transgenic mice: a model for macular degeneration. Proc Natl Acad Sci U S A. 2005;102:4164-4169.
21. Hee MR, Iyatt JA, Swanson EA, et al. Optical coherence tomography of the human retina. Arch Ophthalmol. 1995;113: 325-332.
22. Ergun E, Hermann B, Wirtitsch M, et al. Assessment of central visual function in Stargardt's disease/fundus flavimaculatus with ultrahigh-resolution optical coherence tomography. Invest Ophthalmol Vis Sci. 2005;46:310-316.
23. Srinivasan VJ, Wojtkowski M, Witkin AJ, et al. High-definition and 3-dimensional imaging of macular pathologies with highspeed ultrahigh-resolution optical coherence tomography. Ophthalmology. 2006;113:2054. e1-14. Available at: http:// www.ophsource.org/periodicals/ophtha. Accessed June 29, 2011.
24. Gomes NL, Greenstein VC, Carlson JN, et al. A comparison of fundus autofluorescence and retinal structure in patients with Stargardt disease. Invest Ophthalmol Vis Sci. 2009;50:3953-3959.
25. Landa G, Su E, Garcia PM, Seiple WH, Rosen RB. Inner segment-outer segment junctional layer integrity and corresponding retinal sensitivity in dry and wet forms of age-related macular degeneration. Retina. 2011;31:364-370.
26. Cella W, Greenstein VC, Zernant-Rajang J, et al. G1961E mutant allele in the Stargardt disease gene ABCA4 causes bull's eye maculopathy. Exp Eye Res. 2009;89:16-24.
27. Maguire AM, Simonelli F, Pierce EA, et al. Safety and efficacy of gene transfer for Leber's congenital amaurosis. N Engl J Med. 2008;358:2240-2248.
28. Bainbridge JW, Smith AJ, Barker SS, et al. Effect of gene therapy on visual function in Leber's congenital amaurosis. N Engl J Med. 2008;358:2231-2239.
29. Hauswirth WW, Aleman TS, Kaushal S, et al. Treatment of Leber congenital amaurosis due to RPE65 mutations by ocular subretinal injection of adeno-associated virus gene vector: short-term results of a phase I trial. Hum Gene Ther. 2008;19: 979-990.